What is the general rule for treating suspected acute coronary syndrome in flight?

• A. Observe and wait for landing
• B. Administer aspirin if not contraindicated, provide oxygen, and arrange rapid medical evaluation and descent.
• C. Initiate defibrillation only if pulseless
• D. Administer antihistamines and fluids

Answer: (B)

In suspected acute coronary syndrome during flight, the priority is rapid stabilization and getting the patient definitive care as quickly as possible. The best approach is to give aspirin promptly (if not contraindicated) because it blocks platelets and reduces mortality when ACS is present. If aspirin is safe to administer, a chewable 160–325 mg dose is typically used to start antiplatelet therapy right away.

Next, provide oxygen if the patient is hypoxemic or in distress, since the cabin environment lowers available oxygen and can worsen myocardial ischemia. The goal is to maintain adequate oxygen delivery to the heart, guided by the patient’s oxygen saturation and clinical status.

Finally, arrange for rapid medical evaluation and descent to a facility equipped to manage ACS. Early access to advanced therapies—such as further antithrombotic treatment, nitrates if appropriate, and PCI or thrombolysis when indicated—improves outcomes.

Observing and waiting for landing delays crucial treatment. Defibrillation is not routinelyInitiated for ACS unless there is a dangerous rhythm like ventricular fibrillation or pulseless VT. Antihistamines and fluids do not address ACS and are not appropriate as a general rule.